Live from the NIH registry
Studies recruiting near Allentown right now
Top 25 of 230 recruiting studies, sorted by proximity — each links to its official registry page
Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia
Acute Leukemia, Newly Diagnosed
N/A
Observational 1,365 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Nectero EAST System Clinical Study
Abdominal Aortic Aneurysm
Phase 2, Phase 3
Interventional 400 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Nectero Medical, Inc.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
Relapsing Multiple Sclerosis, Multiple Sclerosis
N/A
Observational 2,000 participants sought
TG Therapeutics Investigational Trial Site — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: TG Therapeutics, Inc.
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Solid Tumors, Hematologic Malignancies
Phase 3
Interventional 3,500 participants sought
St. Luke's University Health Network ( Site 0017) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Merck Sharp & Dohme LLC
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
Graves' Disease
Phase 2
Interventional 240 participants sought
Site Number - 1043 — Pottstown, Pennsylvania (25.9 mi)
· Sponsor: Immunovant Sciences GmbH
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Non-small Cell Lung Cancer, Anaplastic Lymphoma Kinase-positive
Phase 3
Interventional 450 participants sought
Alliance Cancer Specialists — Sellersville, Pennsylvania (19.0 mi)
· Sponsor: Nuvalent Inc.
ANCHOR Study: A Study to Assess the Safety and Efficacy of ABBV-CLS-628 in Adult Participants With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Autosomal Dominant Polycystic Kidney Disease
Phase 2
Interventional 240 participants sought
Northeast Clinical Research Center — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Calico Life Sciences LLC
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
Suicide and Depression, Adolescent Behavior
N/A
Interventional 900 participants sought
Berks Community Health Center — Reading, Pennsylvania (29.8 mi)
· Sponsor: University of Pittsburgh
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
Melanoma
Phase 3
Interventional 560 participants sought
St. Luke's University Health Network — Easton, Pennsylvania (14.8 mi)
· Sponsor: Regeneron Pharmaceuticals
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
Arrhythmia, Bradycardia
N/A
Observational 20,000 participants sought
Research site — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Medtronic
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Phase 2
Interventional 335 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Aptis PRUJ Prosthesis for the Treatment of Patients With Proximal Radial Ulna Joint Disorders.
Arthritis, Unstable Radial Head
N/A
Interventional 84 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Aptis Medical
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Removal of the Bladder, Kidney, Ureter, and Urethra for Urothelial Cancer Treatment, MODERN Study
Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma
Phase 2, Phase 3
Interventional 992 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
Focal Segmental Glomerulosclerosis
Phase 2
Interventional 60 participants sought
Investigator Site #30 — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Akebia Therapeutics
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
Macular Degeneration, Age-Related Macular Degeneration
Phase 2, Phase 3
Interventional 960 participants sought
Mid Atlantic Retina (Site 050) — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: EyeBiotech Ltd.
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Lehigh Valley Hospital - Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: American Society of Clinical Oncology
A Study to Evaluate Efficacy and Safety of Light Dose in Subjects With PWB Treated With Hemoporfin PDT
Port-wine Birthmarks, Port-Wine Stain
Phase 2
Interventional 84 participants sought
St. Luke's University Health Network — Bethlehem, Pennsylvania (5.9 mi)
· Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Breast Cancer
Phase 3
Interventional 3,960 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: NRG Oncology
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL Study
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 247 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: National Cancer Institute (NCI)
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Endometrial Cancer, Endometrioid Adenocarcinoma
N/A
Observational 1,715 participants sought
Lehigh Valley Health Network — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia
Phase 1, Phase 2
Interventional 960 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: PedAL BCU, LLC
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
Advanced Malignant Tumors
Phase 1
Interventional 437 participants sought
Local Institution - 0020 — Allentown, Pennsylvania (1.1 mi)
· Sponsor: Bristol-Myers Squibb
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Metastatic Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v8
Phase 2
Interventional 240 participants sought
Lehigh Valley Hospital-Cedar Crest — Allentown, Pennsylvania (1.1 mi)
· Sponsor: NRG Oncology
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Saint Luke's Cancer Center - Allentown — Allentown, Pennsylvania (1.1 mi)
· Sponsor: SWOG Cancer Research Network